Kolexia
Sanhes Laurence Hématologie
Sanhes Laurence
Hématologie
Centre Hospitalier de Perpignan
Perpignan, France
120 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Syndromes myélodysplasiques Myélome multiple Récidive tumorale locale Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémie lymphoïde Leucémie aigüe myéloïde Lymphome B

Collaborateurs

Voir plus
Fenaux Pierre
Fenaux Pierre
Hôpital Saint-Louis, Paris, France
Gyan Emmanuel
Gyan Emmanuel
Centre hospitalier de Tours, Tours, France
Banos Anne
Banos Anne
Centre Hospitalier de la Côte Basque, Bayonne, France
Cartron Guillaume
Cartron Guillaume
Hôpital Saint-Éloi, Montpellier, France

Industries

Voir plus
AstraZeneca
2 collaboration(s)
Dernière en 2022
Janssen
2 collaboration(s)
Dernière en 2021
Servier
1 collaboration(s)
Dernière en 2021
Pfizer
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Tamibarotene Plus Azacitidine Versus Placebo Plus Azacitidine in Newly Diagnosed, Adult Patients Selected for RARA-positive Higher-risk Myelodysplastic Syndrome (SELECT MDS-1)
Essai Clinique (Syros Pharmaceuticals)   11 mars 2024
Real-World Outcomes of Newly Diagnosed Multiple Myeloma (NDMM) Patients Treated before the Anti-CD38 Antibodies Era in France, the Emmy Cohort 2017 to 2020
65th ASH Annual Meeting Abstracts   02 novembre 2023
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Essai Clinique (The Lymphoma Academic Research Organisation)   25 septembre 2023
EVEREST: Assessment of the Quality of Life of Patients With Lymphomas Treated With Oral Therapy
Essai Clinique (CHU Toulouse)   18 septembre 2023
LAMSA2020: A Phase II Randomized Study to Assess the Efficacy on Outcome of Venetoclax Combined With Cytarabine Versus Idarubicin Combined With Cytarabine Administered as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission
Essai Clinique (French Innovative Leukemia Organisation)   07 septembre 2023
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.
Blood advances   27 juin 2023
Allogeneic transplantation in T-cell lymphoma: Lessons from the AATT study
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
STAIR: STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia
Essai Clinique (French Innovative Leukemia Organisation)   23 mai 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   18 avril 2023
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.
Blood   21 mars 2023